223 related articles for article (PubMed ID: 22271298)
1. The adverse event profile of pregabalin across different disorders: a meta-analysis.
Zaccara G; Perucca P; Gangemi PF
Eur J Clin Pharmacol; 2012 Jun; 68(6):903-12. PubMed ID: 22271298
[TBL] [Abstract][Full Text] [Related]
2. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials.
Zaccara G; Gangemi P; Perucca P; Specchio L
Epilepsia; 2011 Apr; 52(4):826-36. PubMed ID: 21320112
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
French J; Brandt C; Friedman D; Biton V; Knapp L; Pitman V; Chew M; Dubrava S; Posner HB
Epilepsia; 2014 Aug; 55(8):1220-8. PubMed ID: 24962242
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
5. Sexual Dysfunctions Induced by Pregabalin.
Hamed SA
Clin Neuropharmacol; 2018; 41(4):116-122. PubMed ID: 30001248
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.
Arroyo S; Anhut H; Kugler AR; Lee CM; Knapp LE; Garofalo EA; Messmer S;
Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Häuser W; Petzke F; Sommer C
J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
[TBL] [Abstract][Full Text] [Related]
8. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies.
Semel D; Murphy TK; Zlateva G; Cheung R; Emir B
BMC Fam Pract; 2010 Nov; 11():85. PubMed ID: 21054853
[TBL] [Abstract][Full Text] [Related]
12. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.
Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG
Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin for acute and chronic pain in adults.
Moore RA; Straube S; Wiffen PJ; Derry S; McQuay HJ
Cochrane Database Syst Rev; 2009 Jul; (3):CD007076. PubMed ID: 19588419
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
Parsons B; Sanin L; Yang R; Emir B; Juhn M
Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.
Lampl C; Schweiger C; Haider B; Lechner A
J Neurol; 2010 Aug; 257(8):1265-73. PubMed ID: 20221770
[TBL] [Abstract][Full Text] [Related]
17. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.
Huppertz HJ; Feuerstein TJ; Schulze-Bonhage A
Epilepsia; 2001 Jun; 42(6):790-2. PubMed ID: 11422338
[TBL] [Abstract][Full Text] [Related]
18. Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pain.
Gilron I; Tu D; Holden R; Towheed T; Vandenkerkhof E; Milev R
JMIR Res Protoc; 2017 Aug; 6(8):e154. PubMed ID: 28778847
[TBL] [Abstract][Full Text] [Related]
19. Immediate and controlled-release pregabalin for the treatment of epilepsy.
Morano A; Palleria C; Citraro R; Nesci V; De Caro C; Giallonardo AT; De Sarro G; Russo E; Di Bonaventura C
Expert Rev Neurother; 2019 Dec; 19(12):1167-1177. PubMed ID: 31623493
[No Abstract] [Full Text] [Related]
20. [Pregabalin--profile of efficacy and tolerability in neuropathic pain].
Stump P
Drugs Today (Barc); 2009 Oct; 45 Suppl C():19-27. PubMed ID: 20087482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
